Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alva Health is a private digital health and medical device company developing an AI-enabled wearable neuromonitoring platform for real-time stroke detection outside the hospital. The company’s lead product is a wrist-worn, cloud-connected system designed to detect hemiparesis and related stroke signatures, trigger emergency response, and improve time to treatment. Founded as a Yale University spinout, Alva Health operates from Dallas and New Haven and has been supported by non-dilutive funding from organizations including the U.S. National Science Foundation and the National Institutes of Health. The company appears to be in technical and clinical validation and is preparing for an FDA 510(k) submission for initial commercialization. Its business combines wearable hardware, mobile software, cloud monitoring, machine learning, and clinical study operations focused on stroke care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alva Health.